Veracyte (VCYT) Total Non-Current Liabilities (2012 - 2026)

Veracyte's (VCYT) quarterly Total Non-Current Liabilities came in at $91.7 million in Q1 2026, down 23.49% year-on-year from $119.9 million in Q1 2025, and down 3.29% quarter-over-quarter from $94.9 million in Q4 2025.

Veracyte (VCYT) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends

Veracyte has disclosed Total Non-Current Liabilities across 11 years of filings, most recently posting $91.7 million for Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $91.7 million, down 23.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $91.7 million (down 23.49% YoY), and the FY2025 annual result was $94.9 million, down 23.29% from the prior year.
  • Total Non-Current Liabilities came in at $91.7 million for Q1 2026 at Veracyte, down from $94.9 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $123.7 million in Q4 2024 to a low of $70.0 million in Q4 2023.
  • The 5-year median for Total Non-Current Liabilities is $84.8 million (2024), against an average of $90.5 million.
  • Across the five-year window, Total Non-Current Liabilities soared 77.21% in 2022 and decreased 23.49% in 2026, its largest moves.
  • Veracyte's Total Non-Current Liabilities stood at $80.3 million in 2022, then retreated by 12.79% to $70.0 million in 2023, then soared by 76.61% to $123.7 million in 2024, then fell by 23.29% to $94.9 million in 2025, then dropped by 3.29% to $91.7 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $91.7 million (Q1 2026), $94.9 million (Q4 2025), and $109.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn 6.97 Bn
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn 56.93 Bn
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn 25.03 Bn
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn 529.54 Mn
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn 5.45 Bn
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn 737.18 Mn
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn 22.71 Bn
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn 3.53 Bn
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn 3.42 Bn
10 Veracyte 3.91 Bn 3.65 Bn 101.16 Mn 91.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 91.74 Mn
Dec 31, 2025 94.85 Mn
Sep 30, 2025 109.54 Mn
Jun 30, 2025 122.47 Mn
Mar 31, 2025 119.91 Mn
Dec 31, 2024 123.66 Mn
Sep 30, 2024 84.75 Mn
Jun 30, 2024 99.60 Mn
Mar 31, 2024 80.90 Mn
Dec 31, 2023 70.02 Mn
Sep 30, 2023 70.11 Mn
Jun 30, 2023 73.54 Mn
Mar 31, 2023 75.07 Mn
Dec 31, 2022 80.29 Mn
Sep 30, 2022 76.63 Mn
Jun 30, 2022 77.69 Mn
Mar 31, 2022 87.02 Mn
Dec 31, 2021 85.59 Mn
Sep 30, 2021 77.39 Mn
Jun 30, 2021 51.79 Mn